Search for the latest updates on diabetes
News
Resverlogix Completes Enrollment of Phase 2 Clinical Trial of RVX-208 in Patients with Pre-Diabetes Mellitus CNW Group via Yahoo! Finance - 11 minutes
TSX Exchange Symbol: RVX CALGARY , Dec. 23, 2013 /CNW/ - Resverlogix Corp. (RVX.TO) today announced that it has completed enrollment of its ...
Manage alerts · Unsubscribe · Privacy Policy
Tip: To search for an exact phrase, put quotation marks around two or more words.
| You received this email because you subscribed to Yahoo! Alerts. |
No comments:
Post a Comment